SlideShare a Scribd company logo
Start with the great name of ALLAH, the most
beneficial and the most Merciful
45 year male presented with behavioral changes and Seizures.
 2-4 % of all primary brain tumor
 25-33% of glial tumors
 M:F ; 3: 2
 Average 40 years (peak B/w 26-46 year) with smallest
early childhood peak (b/w 6 -12 years)
 CSF metastasis; 10 %
 Spinal ODG; 2.6 % intra-medullary tumor
Oligodendroglial Tumor
Oligodendroglial Tumor
Presentation
 Seizures ; 50 – 80 %
 Headache; 22 %
 Mental status change; 10 %
 Vertigo/ nausea; 9 %
Location
 Supra-tentorial ; 90 %
 Frontal lobe; 45 %
 Hemisphere (except front); 40
%
 With in 3rd and lateral ventricle;
15%
 Infra-tentorial and spine; <10%
 Calcification; 90 % on CT scan
 T2 - weighted well circumscribed, homogeneously
hyper-intense
 T1 weighted, contrast enhanced, heterogenously hypo-
intense with no significant enhancement
 70 % calcified; hypo intense on T1 and T2, but micro
calcification can demonstrate hyperintense on T1
weighted
Radiological Presentation
 73% micro-calcification; 16 % cystic; 33- 41 % have
component of ependymal or neoplastic astrocytoma
 Penetrate intact parenchyma
 Fried egg appearance
 Chicken wire vascular pattern
 Round monotonous nuclei surrounding eccentric rim
of eosinophilic cytoplasm with lacked cell process
 GFAP staining; mostly for astrocyte component
Pathology
 WHO class II (low grade)
 WHO class III (High Grade)
 Smith grading System; compose of five variables
o N/c ratio
o Maximal cell density
o Pleomorphism; related to Survival
o Endothelial proliferation
o Necrosis
Grading System
 1p or 19 q or both allelic loss responses on
chemotherapy
 PVC; Procarbazine 60 mg/m2 IV, CCNU aka lomustine
110 mg/ m2 PO, Vincristine 1.4 mg/m2 all given on 29
days cycle repeated every 6 weeks.
Chemotherapy
Indication of surgery
 Significant mass effect regardless of grade
Without mass effect;
 low grade: gross total resection; improve survival
 High grade: no improvement in survival, either with
gross total or partial de bulking or biopsy
 Pink to red friable mass, can have false plane of
demarcation between tumor and normal brain
parenchyma
Surgery
 Controversial
 Survival is better with > 45 Gy
 No improvement in 5 year survival with or with out
XRT
Post operative Radiation
 Pure ODG have better outcome from astrocyte
component
 Median survival; grade A; 94 months, grade B; 51
months, grade C; 45 months and grade D; 17 months
 10 year survival; surgically treated mean 52 months
 Calcified; 108 months vs Non- calcified 58 month
 Frontal lobe; 37 months vs temporal lobe; 28 months
 Chromosome 1 p loss have longer survival
Prognosis
Thank you
Dr Muzammil

More Related Content

What's hot

Presentation1.pptx sellar and para sellar masses
Presentation1.pptx sellar and para sellar massesPresentation1.pptx sellar and para sellar masses
Presentation1.pptx sellar and para sellar masses
Abdellah Nazeer
 
Presentation2.pptx. posterior fossa tumour
Presentation2.pptx. posterior fossa tumourPresentation2.pptx. posterior fossa tumour
Presentation2.pptx. posterior fossa tumour
Abdellah Nazeer
 
Carotid body tumors
Carotid body tumorsCarotid body tumors
Carotid body tumors
Jason Lepse
 
Craniopharyngiomas
Craniopharyngiomas Craniopharyngiomas
Craniopharyngiomas
suresh Bishokarma
 
Meningioma
MeningiomaMeningioma
Meningioma
Adam Chen
 
2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx
RejoyceAnto
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
DrAyush Garg
 
MANAGEMENT OF PITUITARY TUMORS.pptx
MANAGEMENT OF PITUITARY  TUMORS.pptxMANAGEMENT OF PITUITARY  TUMORS.pptx
MANAGEMENT OF PITUITARY TUMORS.pptx
Kiran Ramakrishna
 
Cp angle tumors
Cp angle tumorsCp angle tumors
Craniopharyngioma
CraniopharyngiomaCraniopharyngioma
Craniopharyngioma
Goutham Hanu
 
Essentials of gliomas
Essentials of gliomas Essentials of gliomas
Essentials of gliomas
NeurologyKota
 
Carcinoma Maxillary sinus
Carcinoma Maxillary sinusCarcinoma Maxillary sinus
Ca oropharynx
Ca oropharynxCa oropharynx
Ca oropharynx
DrAyush Garg
 
Nasopharyngeal cancer
Nasopharyngeal cancer Nasopharyngeal cancer
Nasopharyngeal cancer
Ajay Manickam
 
Ependymoma
EpendymomaEpendymoma
Ependymoma
Inga Nalivaiko
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
DrAyush Garg
 
Tumours of hypopharynx
Tumours of hypopharynxTumours of hypopharynx
Tumours of hypopharynx
Vinay Bhat
 
Nasopharyngeal Carcinoma
Nasopharyngeal CarcinomaNasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Balasubramanian Thiagarajan
 
Temporal bone radiology
Temporal bone radiologyTemporal bone radiology
Temporal bone radiology
Satish Naga
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
AlirezaGolchini1
 

What's hot (20)

Presentation1.pptx sellar and para sellar masses
Presentation1.pptx sellar and para sellar massesPresentation1.pptx sellar and para sellar masses
Presentation1.pptx sellar and para sellar masses
 
Presentation2.pptx. posterior fossa tumour
Presentation2.pptx. posterior fossa tumourPresentation2.pptx. posterior fossa tumour
Presentation2.pptx. posterior fossa tumour
 
Carotid body tumors
Carotid body tumorsCarotid body tumors
Carotid body tumors
 
Craniopharyngiomas
Craniopharyngiomas Craniopharyngiomas
Craniopharyngiomas
 
Meningioma
MeningiomaMeningioma
Meningioma
 
2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx2021 WHO Classification of brain tumours.pptx
2021 WHO Classification of brain tumours.pptx
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
 
MANAGEMENT OF PITUITARY TUMORS.pptx
MANAGEMENT OF PITUITARY  TUMORS.pptxMANAGEMENT OF PITUITARY  TUMORS.pptx
MANAGEMENT OF PITUITARY TUMORS.pptx
 
Cp angle tumors
Cp angle tumorsCp angle tumors
Cp angle tumors
 
Craniopharyngioma
CraniopharyngiomaCraniopharyngioma
Craniopharyngioma
 
Essentials of gliomas
Essentials of gliomas Essentials of gliomas
Essentials of gliomas
 
Carcinoma Maxillary sinus
Carcinoma Maxillary sinusCarcinoma Maxillary sinus
Carcinoma Maxillary sinus
 
Ca oropharynx
Ca oropharynxCa oropharynx
Ca oropharynx
 
Nasopharyngeal cancer
Nasopharyngeal cancer Nasopharyngeal cancer
Nasopharyngeal cancer
 
Ependymoma
EpendymomaEpendymoma
Ependymoma
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
 
Tumours of hypopharynx
Tumours of hypopharynxTumours of hypopharynx
Tumours of hypopharynx
 
Nasopharyngeal Carcinoma
Nasopharyngeal CarcinomaNasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
 
Temporal bone radiology
Temporal bone radiologyTemporal bone radiology
Temporal bone radiology
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 

Similar to Oligodendroglioma

Management in low grade gliomas
Management in low grade gliomasManagement in low grade gliomas
Management in low grade gliomas
Dr pallavi kalbande
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
bkling
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
DeveshAhir
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
DeveshAhir
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
Rejil Rajan
 
Portec 3
Portec 3Portec 3
Portec 3
MUNEER khalam
 
HYPOFRACTIONATION.pptx
HYPOFRACTIONATION.pptxHYPOFRACTIONATION.pptx
HYPOFRACTIONATION.pptx
DR REJIL RAJAN
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptx
DeveshAhir
 
Colorectal cancer - adjuvant Rx - Nicola Tanner
Colorectal cancer - adjuvant Rx - Nicola TannerColorectal cancer - adjuvant Rx - Nicola Tanner
Colorectal cancer - adjuvant Rx - Nicola Tanner
welshbarbers
 
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
Joseph A. Di Como MD
 
Chemotherapy in gliomas
Chemotherapy in gliomas Chemotherapy in gliomas
Chemotherapy in gliomas
Dr Boaz Vincent
 
Ovarian Carcinoma
Ovarian CarcinomaOvarian Carcinoma
Ovarian Carcinoma
FAISALKHAN900
 
advanced stage ovary tumor.pptx
advanced stage ovary tumor.pptxadvanced stage ovary tumor.pptx
advanced stage ovary tumor.pptx
Dr. Sumit KUMAR
 
Cancer ovarian .pptx
Cancer ovarian .pptxCancer ovarian .pptx
Cancer ovarian .pptx
Wesam Al-Magharbeh
 
MANAGEMENT OF GLIOMAS
MANAGEMENT OF GLIOMASMANAGEMENT OF GLIOMAS
MANAGEMENT OF GLIOMAS
Isha Jaiswal
 
Small cell lung cancer
Small cell lung cancerSmall cell lung cancer
Small cell lung cancer
redho1
 
02 ptcl ylk
02 ptcl  ylk02 ptcl  ylk
02 ptcl ylk
spa718
 
CNS tumors_MG
CNS tumors_MGCNS tumors_MG
CNS tumors_MG
Michael Guiou
 
Pancreatic cancer Management (pancreatic adenocarcinoma)
Pancreatic cancer Management (pancreatic adenocarcinoma)Pancreatic cancer Management (pancreatic adenocarcinoma)
Pancreatic cancer Management (pancreatic adenocarcinoma)
Dr mohamed Salat Gonjobe
 
Omission of RT in elderly breast cancer patients
Omission of RT in  elderly breast cancer patientsOmission of RT in  elderly breast cancer patients
Omission of RT in elderly breast cancer patients
Bharti Devnani
 

Similar to Oligodendroglioma (20)

Management in low grade gliomas
Management in low grade gliomasManagement in low grade gliomas
Management in low grade gliomas
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
Ovarian cancer .pptx
Ovarian cancer .pptxOvarian cancer .pptx
Ovarian cancer .pptx
 
HYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPYHYPOFRACTIONATION IN RADIOTHERAPY
HYPOFRACTIONATION IN RADIOTHERAPY
 
Portec 3
Portec 3Portec 3
Portec 3
 
HYPOFRACTIONATION.pptx
HYPOFRACTIONATION.pptxHYPOFRACTIONATION.pptx
HYPOFRACTIONATION.pptx
 
ovarian cancer.pptx
ovarian cancer.pptxovarian cancer.pptx
ovarian cancer.pptx
 
Colorectal cancer - adjuvant Rx - Nicola Tanner
Colorectal cancer - adjuvant Rx - Nicola TannerColorectal cancer - adjuvant Rx - Nicola Tanner
Colorectal cancer - adjuvant Rx - Nicola Tanner
 
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
Soft tissue sarcomas, treatment (surgical, radiation, chemotherapy)
 
Chemotherapy in gliomas
Chemotherapy in gliomas Chemotherapy in gliomas
Chemotherapy in gliomas
 
Ovarian Carcinoma
Ovarian CarcinomaOvarian Carcinoma
Ovarian Carcinoma
 
advanced stage ovary tumor.pptx
advanced stage ovary tumor.pptxadvanced stage ovary tumor.pptx
advanced stage ovary tumor.pptx
 
Cancer ovarian .pptx
Cancer ovarian .pptxCancer ovarian .pptx
Cancer ovarian .pptx
 
MANAGEMENT OF GLIOMAS
MANAGEMENT OF GLIOMASMANAGEMENT OF GLIOMAS
MANAGEMENT OF GLIOMAS
 
Small cell lung cancer
Small cell lung cancerSmall cell lung cancer
Small cell lung cancer
 
02 ptcl ylk
02 ptcl  ylk02 ptcl  ylk
02 ptcl ylk
 
CNS tumors_MG
CNS tumors_MGCNS tumors_MG
CNS tumors_MG
 
Pancreatic cancer Management (pancreatic adenocarcinoma)
Pancreatic cancer Management (pancreatic adenocarcinoma)Pancreatic cancer Management (pancreatic adenocarcinoma)
Pancreatic cancer Management (pancreatic adenocarcinoma)
 
Omission of RT in elderly breast cancer patients
Omission of RT in  elderly breast cancer patientsOmission of RT in  elderly breast cancer patients
Omission of RT in elderly breast cancer patients
 

More from Zeeshan Nasir

Anterior-o-lateral approach to thoraco lumbar region
Anterior-o-lateral approach to thoraco lumbar regionAnterior-o-lateral approach to thoraco lumbar region
Anterior-o-lateral approach to thoraco lumbar region
Zeeshan Nasir
 
Anterior Cervical Corpectomy
Anterior Cervical CorpectomyAnterior Cervical Corpectomy
Anterior Cervical Corpectomy
Zeeshan Nasir
 
Chiari I Decompression
Chiari I DecompressionChiari I Decompression
Chiari I Decompression
Zeeshan Nasir
 
Surgical management of Spasticity
Surgical management of SpasticitySurgical management of Spasticity
Surgical management of Spasticity
Zeeshan Nasir
 
Low grade Glioma
Low grade Glioma Low grade Glioma
Low grade Glioma
Zeeshan Nasir
 
Radiology of Spine
Radiology of Spine Radiology of Spine
Radiology of Spine
Zeeshan Nasir
 
MRI brain
MRI brain MRI brain
MRI brain
Zeeshan Nasir
 
Diffuse astrocytoma
Diffuse astrocytomaDiffuse astrocytoma
Diffuse astrocytoma
Zeeshan Nasir
 

More from Zeeshan Nasir (8)

Anterior-o-lateral approach to thoraco lumbar region
Anterior-o-lateral approach to thoraco lumbar regionAnterior-o-lateral approach to thoraco lumbar region
Anterior-o-lateral approach to thoraco lumbar region
 
Anterior Cervical Corpectomy
Anterior Cervical CorpectomyAnterior Cervical Corpectomy
Anterior Cervical Corpectomy
 
Chiari I Decompression
Chiari I DecompressionChiari I Decompression
Chiari I Decompression
 
Surgical management of Spasticity
Surgical management of SpasticitySurgical management of Spasticity
Surgical management of Spasticity
 
Low grade Glioma
Low grade Glioma Low grade Glioma
Low grade Glioma
 
Radiology of Spine
Radiology of Spine Radiology of Spine
Radiology of Spine
 
MRI brain
MRI brain MRI brain
MRI brain
 
Diffuse astrocytoma
Diffuse astrocytomaDiffuse astrocytoma
Diffuse astrocytoma
 

Recently uploaded

Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
MuskanShingari
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
Healthmedsrx.com
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
MRI for Surgeons introduction and basics
MRI for Surgeons  introduction and basicsMRI for Surgeons  introduction and basics
MRI for Surgeons introduction and basics
rohitsharma19711
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
shruti jagirdar
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 

Recently uploaded (20)

Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
MRI for Surgeons introduction and basics
MRI for Surgeons  introduction and basicsMRI for Surgeons  introduction and basics
MRI for Surgeons introduction and basics
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 

Oligodendroglioma

  • 1. Start with the great name of ALLAH, the most beneficial and the most Merciful
  • 2. 45 year male presented with behavioral changes and Seizures.
  • 3.  2-4 % of all primary brain tumor  25-33% of glial tumors  M:F ; 3: 2  Average 40 years (peak B/w 26-46 year) with smallest early childhood peak (b/w 6 -12 years)  CSF metastasis; 10 %  Spinal ODG; 2.6 % intra-medullary tumor Oligodendroglial Tumor
  • 4. Oligodendroglial Tumor Presentation  Seizures ; 50 – 80 %  Headache; 22 %  Mental status change; 10 %  Vertigo/ nausea; 9 % Location  Supra-tentorial ; 90 %  Frontal lobe; 45 %  Hemisphere (except front); 40 %  With in 3rd and lateral ventricle; 15%  Infra-tentorial and spine; <10%
  • 5.  Calcification; 90 % on CT scan  T2 - weighted well circumscribed, homogeneously hyper-intense  T1 weighted, contrast enhanced, heterogenously hypo- intense with no significant enhancement  70 % calcified; hypo intense on T1 and T2, but micro calcification can demonstrate hyperintense on T1 weighted Radiological Presentation
  • 6.
  • 7.  73% micro-calcification; 16 % cystic; 33- 41 % have component of ependymal or neoplastic astrocytoma  Penetrate intact parenchyma  Fried egg appearance  Chicken wire vascular pattern  Round monotonous nuclei surrounding eccentric rim of eosinophilic cytoplasm with lacked cell process  GFAP staining; mostly for astrocyte component Pathology
  • 8.
  • 9.  WHO class II (low grade)  WHO class III (High Grade)  Smith grading System; compose of five variables o N/c ratio o Maximal cell density o Pleomorphism; related to Survival o Endothelial proliferation o Necrosis Grading System
  • 10.
  • 11.  1p or 19 q or both allelic loss responses on chemotherapy  PVC; Procarbazine 60 mg/m2 IV, CCNU aka lomustine 110 mg/ m2 PO, Vincristine 1.4 mg/m2 all given on 29 days cycle repeated every 6 weeks. Chemotherapy
  • 12. Indication of surgery  Significant mass effect regardless of grade Without mass effect;  low grade: gross total resection; improve survival  High grade: no improvement in survival, either with gross total or partial de bulking or biopsy  Pink to red friable mass, can have false plane of demarcation between tumor and normal brain parenchyma Surgery
  • 13.  Controversial  Survival is better with > 45 Gy  No improvement in 5 year survival with or with out XRT Post operative Radiation
  • 14.  Pure ODG have better outcome from astrocyte component  Median survival; grade A; 94 months, grade B; 51 months, grade C; 45 months and grade D; 17 months  10 year survival; surgically treated mean 52 months  Calcified; 108 months vs Non- calcified 58 month  Frontal lobe; 37 months vs temporal lobe; 28 months  Chromosome 1 p loss have longer survival Prognosis